Get Adobe Flash player

Dr. David W. Hobson
Chief Scientific Officer

Dr. David Hobson is a Principal at LoneStarPharmTox LLC. and a noted consultant to government and industry on product and technology development issues for dermatologic, wound healing and tissue repair therapeutics. He was formerly Vice President for Research and Development fot Chrysalis Biotechnology; Vice President of Medical Product Research and Development for Healthpoint, Ltd.; Director of Pharmaceutical Sciences at DPT Laboratories Ltd.; Vice President and a Research Fellow at Battelle Memorial Institute; and Director of Applied Toxicology for the Naval Medical Research Institute of the U.S. Navy.

Dr. Hobson is a Diplomat of the American Board of Toxicology and a Nuclear Medicine instructor at the University of the Incarnate Word in San Antonio, Texas. He has chaired and presented in nanotoxicology sessions at the Society of Toxicology and the Environmental Mutagen Society with an emphasis on early-stage recognition and resolution of nanotoxicology issues to support a developing and promising industry. Dr. Hobson has authored or co-authored several articles and book chapters on dermatoxicology, gastrointestinal toxicology, pharmacology and toxicology study design, nanomaterials safety, pharmaceutical manufacturing and product formulation, as other aspects of pharmaceutical research and development.

Dr. Hobson holds a Bachelor of Science degree from the University of Nebraska as well as Master of Science and Doctor of Philosophy degrees from Texas A&M University in Toxicology.

Robin C. Guy, MS, DABT, RQAP (GLP)
GLP Consultant

Robin C. Guy has been a Toxicology and GLP consultant for more than eight years for Robin Guy Consulting, LLC. She was formerly a toxicologist with Monsanto/The NutraSweet Company/Searle for 19 years. Ms. Guy’s toxicology expertise centers on the safety assessment and regulatory approval of food ingredients and pharmaceutical compounds. She assists companies and employees with Good Laboratory Practice training and consulting, including setting up quality systems for laboratories.

Ms. Guy is a Diplomat of the American Board of Toxicology and a Registered Quality Assurance Professional certified in Good Laboratory Practices. She has authored numerous publications and has presented and chaired symposia at scientific meetings.

Ms. Guy received her Bachelors and Masters Degrees of Science from the University of Illinois.

Robert H. Hurt, Ph.D.

Professor Hurt conducts research on energy and environmental topics with special emphasis on the synthesis, structure, and application of carbon materials and nanomaterials.

  • Professor of Engineering, Brown University, Providence, RI
  • Editor, Carbon
  • Member of Editorial Board for Combustion and Flame
  • 2006 Program Chair for the American Chemical Society Division of Fuel
  • Chemistry Technical Program Chair, Carbon 2004
  • Editor of Carbon special edition on Nanotoxicology
  • Founding member of Nanomaterials Safety Working Group at Brown University

Larry Gibbs, MPH, CIH

Larry Gibbs is Associate Vice-Provost for Environmental Health and Safety at Stanford University, a position he has held since 1992, where he is responsible for all health, safety, and environmental risk management programs in addition to oversight of institutional emergency planning.

Prior to his appointment at Stanford, he held positions with similar responsibility at Yale University, where he also served as adjunct faculty in the School of Public Health, and at the University of Connecticut. He has a graduate degree in chemistry education from Boston University and in industrial hygiene and public health from the University of Michigan.

His work at Stanford University involves health, safety and environmental management oversight of nanotechnology research centers on campus, including the Stanford Nanofabrication Laboratory, a myriad of nanotechnology research conducted in materials science and engineering and at the Stanford medical school. A major element of Mr. Gibbs’ work has focused on issues of risk communication regarding hazardous materials in the workplace and the community.

Mr. Gibbs is a certified industrial hygienist with over 25 years of experience in developing, implementing and managing safety, health and environmental programs for academic, research and clinical institutions. In addition to his work at the universities, he serves as a consultant for industrial, pharmaceutical, biotechnology and government organizations.

He has authored over 25 publications on health, safety and environmental management and co-authored two books.

Mr. Gibbs is active in a number of professional organizations. He is currently on the Board of Directors of the National Association of Environmental Managers, serves on the Executive Council of the Campus Safety, Health and Environmental Management Association, and is active in the American Industrial Hygiene Association, where he founded the AIHA Laboratory Health and Safety Committee.

He recently was elected to Chair-Elect of the American Conference of Governmental Industrial Hygienists and has served on the Board of the American Biological Safety Association.

Nancy Ann Monteiro-Riviere, Ph.D., Fellow ATS

Nancy Ann Monteiro-Riviere, Ph.D. is a Professor of Investigative Dermatology and Toxicology in the Center for Chemical Toxicology Research and Pharmacokinetics, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University (NCSU) in Raleigh, NC.

She received her B.S. in Biology (cum laude) from Stonehill College in North Easton, MA and her M.S. and Ph.D. in Anatomy from Purdue University in West Lafayette, IN. She completed post-doctoral training in Experimental Pathology/Toxicology at the Chemical Industry Institute of Toxicology in Research Triangle Park, NC.

Dr. Monteiro-Riviere joined the faculty of NCSU in 1984. She is also a Professor in the SCSU/UNC-CH Biomedical Engineering Faculty and a Research Adjunct Professor in the Department of Dermatology, School of Medicine at the University of North Carolina at Chapel Hill.

Dr. Monteiro-Riviere is a Fellow in the Academy of Toxicological Sciences and a founding member of the American Academy of Nanomedicine. She also is past president f the Dermal Toxicology Specialty Section and the In Vitro Specialty Section of the Society of Toxicology.

Presently, she serves on the NIH Scientific Advisory Committee on Alternative Toxicological methods, the Board of Publications of the Society of Toxicology, Journal of Toxicology–Cutaneous and Ocular, Toxicology in Vitro, and Toxicology Mechanisms and Methods.

Dr. Monteiro-Riviere has published more than 160 publications, holds a U.S. patent and has been the recipient of millions of dollars in extramural research support from various government and private sources. Her current research interests relate to chemical absorption and mechanisms of chemical irritation to skin.

  • Associate Editor, Nanomedicine: A Multidisciplinary Review
  • Editorial Board, Journal of Applied Toxicology
  • Society of Toxicology Chemical/Biological Terrorism Resource Registry
  • U.S. EPA Scientific Advisory Panel for Federal Insecticide, Fungicide and Rodenticide Act
  • National Institute of Environmental Health Sciences, Scientific Advisory Committee on Alternative Toxicological methods–Advisory to Interagency Coordination Committee on the Validation of Alternative Methods
  • Health and Environmental Sciences Institure, International Life Sciences Institute Health and Environmental Sciences Institute
  • Nanomaterials Safety Subcommittee
  • International Life Sciences Institute–Risk Sciences Institute Nanomaterial Toxicity Screening Work Group

Ivonne Rietjens, Ph.D.

Dr. I.M.C.M. Rietjens is a Professor of Toxicology at Wageningen University in the Netherlands and engaged in research studies in the area of agrotechnology and food sciences. Most recently, she developed quantitative structure activity models using in vitro and insilico data to predict the in vivo toxicity of chlorinated alkanes to fish.

Dr. Rietjens has been a faculty member in the Bio-Nanotechnology, International Advanced Course, conducted by Wageringen University and has authored or co-authored numerous research articles concerned with the toxicology of food and agricultural products.

James Riviere, DVM, Ph.D.

James E. Riviere is the Burroughs Welcome Fund Distinguished Professor of Pharmacology; Director of the Center for Chemical Toxicology Research and Pharmacokinetics; and Director of the Biomathematics Programs of the College of Physical and Mathematical Sciences, North Carolina State University in Raleigh, NC. He is an elected member of the Institute of Medicine of the National Academies and a fellow of the Academy of Toxicological Sciences and has served on the Science Board of the Food and Drug Administration.

Dr. Riviere received his B.S. (summa cum laude) and M.S. degrees from Boston College and his D.V.M. and Ph.D. in pharmacology from Purdue University. He is a member of Phi Beta Kappa, Phi Zeta and Sigma Xi. His honors include the 1999 O. Max Gardner Award from the Board of Governors of the Consolidated University of North Carolina; the 1991 Ebert Prize from the American Pharmaceutical Association; and the Harvey W. Wiley Metal and FDA Commissioner’s Special Citation.

Dr. Riviere is editor of the Journal of Veterinary Pharmacology and Therapeutics and co-founder and co-director of the USDA Food Animal Residue Avoidance Databand program.

He is past president of the Dermatotoxicology Specialty Section of the Society of Toxicology and is a member of the Editorial Board of Toxicology and Applied Pharmacology, as well as Skin Pharmacology and Applied Skin Physiology.

Dr. Riviere hold five U.S. patents and has had extramural research support from both government and industry totaling more than $15 million on grants for which he was principal investigator. He has published more than 400 full-length research papers and chapters and has authored or edited 10 books on pharmacokinetics, toxicology and food safety.

His current research interests relate to applying biomathematics to problems in toxicology, including the risk assessment of chemical mixtures, pharmacokinetics, absorption of drugs and chemicals across skin, and the food safety and pharmacokinetics of tissue residues in food producing animals.

Stephen M. Roberts, Ph.D.

Dr. Stephen Roberts is Director of the Center for Environmental and Human Toxicology at the University of Florida. He also is a professor with joint appointments in the Department of Physiological Sciences in the College of Veterinary Medicine and the Department of Pharmacology and Therapeutics in the College of Medicine.

He received his Ph.D. from the University of Utah College of Medicine in 1977 and subsequently completed a National Institutes of Health individual postdoctoral fellowship in pharmacokinetics at the State University of New York in Buffalo, NY. He previously served on the faculties of the College of Pharmacy at the University of Cincinnati and the College of Medicine at the University of Arkansas for Medical Sciences.

Dr. Roberts has an active research program funded by the NIH to examine mechanisms of toxicity, primarily involving the liver and immune system. His teaching responsibilities at the University of Florida include graduate courses in toxicology and risk assessment, as well as invited lectures in other graduate and professional courses.

Dr. Roberts is an advisor to the Florida Department of Environmental Protection on issues pertaining to toxicology and risk assessment. He also serves on the Committee on Bioavailability of Contaminants in Soils and Sediments for the National Research Council and on the Board of Scientific Counselors for the National Toxicology Program.

  • Editorial Board, Toxicology and Applied Toxicology
  • Editorial Board, Human and Ecological Risk Assessment
  • Editorial Board, Nonlinearity in Biology-Toxicology-Medicine

Michael H. DePledge, Ph.D.

Michael Depledge holds the Chair of Environment and Human Health at the Peninsula Medical School (Universities of Exeter and Plymouth), Devon, UK. He is a Commissioner of the Royal Commission on Environmental Pollution, a board member of Natural England and Visiting Professor both at the Department of Zoology, Oxford University (2007-ongoing) and the School of Earth Sciences and Engineering, Imperial College, London, UK (2002-ongoing). He is also Strategic Advisor to the Vice Chancellor of the University of Westminster.

Professor Depledge was educated at Westfield College, University of London where he gained a First Class Honours degree in Biological Sciences, (1975) and a PhD in the toxicology of marine organisms (1978). As a post-doctoral research fellow at the Brompton Hospital, London he studied lung damage in the severely ill. Later, as a clinical scientist at the Royal Marsden Hospital, he investigated toxicity associated with whole body irradiation and bone marrow transplantation used in the treatment of leukaemia (1979-1982). In 1982 he became Lecturer in Physiology at the medical school of the University of Hong Kong and in 1987 was appointed to the first Chair of Ecotoxicology in Europe at Odense University, Denmark aged 33 years. In 1994 he returned to the UK to take up the Chair of Marine Biology and Ecotoxicology at the University of Plymouth. He was the founding Director of the Plymouth Environmental Research Centre in 1996. Professor Depledge was invited to become the Chief Scientific Advisor of the UK Government’s Environment Agency in September 2002. After a 4 year term in which he produced the Agency’s first ever Science Strategy and created a Europe-wide partnership among the science departments of EU member state environment agencies, he returned to academia to take up his current Chair. At the same time he became Senior Science Advisor at Plymouth Marine Laboratory (the latter until Sept, 2007).

Professor Depledge has published more than 350 peer-reviewed scientific papers in leading international journals and books. He was awarded a Doctor of Science (DSc) degree by the University of London (1996) in recognition of major scientific contributions to the fields of comparative toxicology and medical toxicology. Since 1990 he has been an expert advisor on marine pollution to the United Nations, working in Brazil, Costa Rica, India, Vietnam and several other countries to develop the RAMP (Rapid Assessment of Marine Pollution) programme for UNEP’s Global Oceans Observing System (GOOS). He also serves as an expert advisor to the World Health Organisation (2001- ongoing). He was Honorary Visiting Professor at the School of Public Health, Harvard University, USA (1998 to 2004), and is a former Keeley Visiting Fellow at Wadham College, Oxford University.

Professor Depledge was a board member of the Natural Environment Research Council (NERC) from 2002 to 2006, and is a former member of UK Government’s Chief Scientific Advisors Committee (CSAC) and the Science and Society Champions Network. He was a member of the Royal Society’s task force on “Ground level ozone in the 21st Century” and is currently chairman of the Science Advisory Group for Environment and Climate Change in DG-Research, European Commission in Brussels.

Professor Depledge has given several hundred lectures at international conferences, workshops, universities and research institutes over the past 30 years, to a wide range of audiences.

 
Welcome To nanoTox

Alternative flash content

You need to upgrade your Flash Player

Get Adobe Flash player

Search Our Site
Info Links

Fact Sheet for Nanotechnology under the Toxic Substances Control Act | Prevention, Pesticides and Toxics (OPPTS) | US EPA
EPA